ForumIAS LATEST
- 26 June | Read Less, Revise More: IFoS AIR 36 Nikhil's UPSC Strategy | Click Here to Watch →
- 27 June | How to Score 300+ in Philosophy Optional by Yogita Singh Dhami | Click Here to Watch →
- 28 June | Public Administration OGP Advanced Open Class by Ajeet Sir | Click Here to Watch →
Source : Click here
News: A new drug called Molnupiravir has been shown to stop the transmission of SARS-CoV-2 (COVID-19) in 24 hours.
Facts:
- Molnupiravir: It is an experimental antiviral drug which is orally active (can be taken orally) and was developed for the treatment of influenza.
- Developed by: The drug is being developed by the biotechnology firm Ridgeback Biotherapeutics in collaboration with pharmaceutical firm Merck.
- Significance: This is the first demonstration of an orally available drug to rapidly block SARS-CoV-2 transmission and it can be a game-changer
